Vitamin D and COVID-19, it helps

  • Context: COVID 
  • Thread starter Thread starter Tom.G
  • Start date Start date
  • Tags Tags
    Covid-19
Click For Summary

Discussion Overview

The discussion centers on the relationship between Vitamin D levels and COVID-19 outcomes, exploring potential benefits, associated health risks, and demographic factors. Participants examine various studies, anecdotal evidence, and editorial concerns regarding the efficacy of Vitamin D supplementation in the context of COVID-19.

Discussion Character

  • Exploratory
  • Debate/contested
  • Technical explanation

Main Points Raised

  • Some participants reference a study suggesting that sufficient Vitamin D levels (at least 30 ng/mL) may reduce adverse clinical outcomes in COVID-19 patients.
  • Others discuss the potential link between Vitamin D deficiency and increased cardiac risk, particularly during winter months when sunlight exposure is limited.
  • One participant notes that while the idea of Vitamin D supplements improving COVID-19 conditions is compelling, existing research does not support this claim.
  • A participant highlights an editorial concern regarding the initial study, indicating that it may be misleading.
  • Another point raised discusses the varying Vitamin D production based on skin pigmentation and its potential implications for COVID-19 death rates among different racial groups.
  • One participant challenges the notion that higher COVID-19 death rates in certain racial groups are primarily due to Vitamin D levels, suggesting that preexisting health conditions and access to healthcare are more significant factors.

Areas of Agreement / Disagreement

Participants express a range of views on the relationship between Vitamin D and COVID-19, with no consensus reached. Some support the idea of a beneficial link, while others question its validity and emphasize alternative factors influencing health outcomes.

Contextual Notes

Limitations include the lack of consensus on the effectiveness of Vitamin D supplementation, the dependence on specific study findings, and the potential influence of various demographic and health factors on COVID-19 outcomes.

Tom.G
Science Advisor
Gold Member
Messages
5,661
Reaction score
4,507
Published Sep. 25, 2020 in PLOS ONE:

Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection

Vitamin D [1,25-dihydroxyvitamin D; 1,25(OH)2D] blood level should be 30-55ng/ml for safe effectiveness. The video below also gives daily dosage in I.U. (1500-2000 I.U. daily for adults; 2 - 3 times as much if obese))

The article is rather dense.
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0239799

The 4.5 minute video at the end easily gives you the important conclusions.
https://doi.org/10.1371/journal.pone.0239799.s001
 
  • Like
Likes   Reactions: Fervent Freyja, Astronuc and Doc Al
Biology news on Phys.org
There have been studies linking Vitamin-D to lower cardiac risk, or lower heart disease, and heart disease is a leading comorbidity with COVID-19 (SARS-Cov-2). Scientific American has an article showing deaths per week due to COVID-19 in the US. One point of interest is the cyclical nature of deaths due to heart disease with the greatest rates in the winter, late December to early January, which coincides with holidays (feasting), cold weather and short days. Could one reason be the deficiency of Vitamin-D produced in the skin due to reduced sunlight and the fact that people wear more covering in the cold? Could seasonal affective disorder play a role?

https://www.scientificamerican.com/...the-third-leading-cause-of-death-in-the-u-s1/

The last figure in the article shows the causes on the plot. I'm not sure of the level of peer-review regarding the data.
 
There is an editorial expression of concern about the paper in the OP - meaning the editors now think it could be misleading, although they didn't realize it when they accepted the paper.

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0240965
Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
The PLOS ONE Editors
 
  • Like
Likes   Reactions: Astronuc
An interesting coincidence related to vitamin D:
People with dark skin, such as those of African, African-Caribbean or south Asian origin, will need to spend longer in the sun to produce the same amount of vitamin D as someone with lighter skin.
Source:
https://www.nhs.uk/live-well/healthy-body/how-to-get-vitamin-d-from-sunlight/

Pacific Islander, Latino, Indigenous and Black Americans all have a COVID-19 death rate of double or more that of White and Asian Americans, who experience the lowest age-adjusted rates.
Source:
https://www.apmresearchlab.org/covid/deaths-by-race
 
@Sagittarius A-Star Well I don't think that black etc race deaths are higher because of vitamin D because given most of these folks live in climate with lots more sun than the average white race gets in Europe or North America it wouldn't make sense.

I think it mainly has to do with preexisting conditions and and overall health condition at the moment of infection. It could also be that the ability to have quality and modern healthcare for those that have a critical and bad case of Covid is a very determining factor in the total number of deaths within certain population.
 
  • Like
Likes   Reactions: atyy and Sagittarius A-Star

Similar threads

  • · Replies 21 ·
Replies
21
Views
3K
  • · Replies 8 ·
Replies
8
Views
2K
  • · Replies 4 ·
Replies
4
Views
3K